Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon

Neurosurgical Focus

Volumn 25, Issue 5, 2008, Pages

  Rowland, James W ^a   Hawryluk, Gregory W J ^a,b   Kwon, Brian ^d   Fehlings, Michael G ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Free radical; Glial scar; Ischemia; Myelin; Regeneration; Spinal cord injury; Stem cell

Indexed keywords

ACUTE DISEASE; ANIMAL; HUMAN; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SPINAL CORD INJURY;

ACUTE DISEASE; ANIMALS; HUMANS; NERVE REGENERATION; SPINAL CORD INJURIES;

EID: 63849340879     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/FOC.2008.25.11.E2     Document Type: Article

References (173)

1. Ackery A, Robins S, Fehlings MG: Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma 23:604-616, 2006
2. Akiyama Y, Honmou O, Kato T, et al: Transplantation of clonal neural precursor cells derived from adult human brain establishes functional peripheral myelin in the rat spinal cord. Exp Neurol 167:27-39, 2001
3. Akiyama Y, Radtke C, Kocsis JD: Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 22:6623-6630, 2002
4. Anonymous: Spinal cord injury. Facts and figures at a glance. J Spinal Cord Med 28:379-380, 2005
5. Ao Q, Wang AJ, Chen GQ, et al: Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries. Med Hypotheses 69:1234-1237, 2007
6. Aoyama T, Hida K, Akino M, et al: Ultra-early MRI showing no abnormality in a fall victim presenting with tetraparesis. Spinal Cord 45:695-699, 2007
7. Austin JW, Fehlings MG: Molecular mechanisms of Fas-mediated cell death in oligodendrocytes. J Neurotrauma 25:411- 426, 2008
8. Bao F, Liu D: Peroxynitrite generated in the rat spinal cord induces apoptotic cell death and activates caspase-3. Neuroscience 116:59-70, 2003
9. Baptiste DC, Fehlings MG: Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 23:318-334, 2006
10. Barbeau H, Rossignol S: Recovery of locomotion after chronic spinalization in the adult cat. Brain Res 412:84-95, 1987
11. Barritt AW, Davies M, Marchand F, et al: Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci 26:10856-10867, 2006
12. Beattie MS, Harrington AW, Lee R, et al: ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36:375-386, 2002
13. Beattie MS, Hermann GE, Rogers RC, et al: Cell death in models of spinal cord injury. Prog Brain Res 137:37-47, 2002
14. Benson MD, Romero MI, Lush ME, et al: Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc Natl Acad Sci U S A 102:10694-10699, 2005
15. Bethea JR, Nagashima H, Acosta MC, et al: Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16:851-863, 1999
16. Biernaskie J, Sparling JS, Liu J, et al: Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci 27:9545-9559, 2007
17. Boyd JG, Doucette R, Kawaja MD: Defining the role of olfactory ensheathing cells in facilitating axon remyelination following damage to the spinal cord. FASEB J 19:694-703, 2005
18. Boyd JG, Skihar V, Kawaja M, et al: Olfactory ensheathing cells: historical perspective and therapeutic potential. Anat Rec B New Anat 271:49-60, 2003
19. Bradbury EJ, Moon LD, Popat RJ, et al: Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636-640, 2002
20. Bregman BS, Kunkel-Bagden E, Schnell L, et al: Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378:498-501, 1995
21. Brustle O, Jones KN, Learish RD, et al: Embryonic stem cellderived glial precursors: a source of myelinating transplants. Science 285:754-756, 1999
22. Buffo A, Zagrebelsky M, Huber AB, et al: Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured Purkinje cell axons. J Neurosci 20:2275-2286, 2000
23. Bunge RP, Puckett WR, Becerra JL, et al: Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 59:75-89, 1993
24. Caggiano AO, Zimber MP, Ganguly A, et al: Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J Neurotrauma 22:226-239, 2005
25. Cai D, Qiu J, Cao Z, et al: Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci 21:4731-4739, 2001
26. Caroni P, Schwab ME: Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1:85-96, 1988
27. Casha S, Yu WR, Fehlings MG: FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp Neurol 196:390-400, 2005
28. Casha S, Yu WR, Fehlings MG: Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103:203-218, 2001
29. Chaisuksunt V, Zhang Y, Anderson PN, et al: Axonal regeneration from CNS neurons in the cerebellum and brainstem of adult rats: correlation with the patterns of expression and distribution of messenger RNAs for L1, CHL1, c-jun and growthassociated protein-43. Neuroscience 100:87-108, 2000
30. Chau C, Barbeau H, Rossignol S: Early locomotor training with clonidine in spinal cats. J Neurophysiol 79:392-409, 1998
31. Chen MS, Huber AB, van der Haar ME, et al: Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403:434-439, 2000
32. Cheng B, Christakos S, Mattson MP: Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12:139- 153, 1994
33. Cheng H, Cao Y, Olson L: Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 273:510-513, 1996
34. Cheng H, Liao KK, Liao SF, et al: Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine 29:E284-E288, 2004
35. Chernoff GF: Shiverer: an autosomal recessive mutant mouse with myelin deficiency. J Hered 72:128, 1981
36. Chu GK, Yu W, Fehlings MG: The p75 neurotrophin receptor is essential for neuronal cell survival and improvement of functional recovery after spinal cord injury. Neuroscience 148:668-682, 2007
37. Coleman MP, Perry VH: Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 25:532-537, 2002
38. Crowe MJ, Bresnahan JC, Shuman SL, et al: Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3:73-76, 1997
39. Cummings BJ, Uchida N, Tamaki SJ, et al: Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A 102:14069- 14074, 2005
40. David S, Aguayo AJ: Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science 214:931-933, 1981
41. David S, Aguayo AJ: Axonal regeneration after crush injury of rat central nervous system fibres innervating peripheral nerve grafts. J Neurocytol 14:1-12, 1985
42. Dergham P, Ellezam B, Essagian C, et al: Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 22:6570-6577, 2002
43. Devon R, Doucette R: Olfactory ensheathing cells myelinate dorsal root ganglion neurites. Brain Res 589:175-179, 1992
44. Ditunno JF, Little JW, Tessler A, et al: Spinal shock revisited: a four-phase model. Spinal Cord 42:383-395, 2004
45. Dobkin BH, Curt A, Guest J: Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair 20:5-13, 2006
46. Donnelly DJ, Popovich PG: Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209:378-388, 2007
47. Dubreuil CI, Winton MJ, McKerracher L: Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol 162:233- 243, 2003
48. Edgerton VR, Kim SJ, Ichiyama RM, et al: Rehabilitative therapies after spinal cord injury. J Neurotrauma 23:560- 570, 2006
49. Eftekharpour E, Karimi-Abdolrezaee S, Wang J, et al: Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J Neurosci 27:3416-3428, 2007
50. Ehlers MD: Deconstructing the axon: Wallerian degeneration and the ubiquitin-proteasome system. Trends Neurosci 27:3-6, 2004
51. Emery E, Aldana P, Bunge MB, et al: Apoptosis after traumatic human spinal cord injury. J Neurosurg 89:911-920, 1998
52. Evans MJ, Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156, 1981
53. Fehlings MG: Summary statement: the use of methylprednisolone in acute spinal cord injury. Spine 26:S55, 2001
54. Fehlings MG, Tator CH: The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 132:220-228, 1995
55. Filippi M, Rocca MA: Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics 4:401-413, 2007
56. Fleming JC, Norenberg MD, Ramsay DA, et al: The cellular inflammatory response in human spinal cords after injury. Brain 129:3249-3269, 2006
57. Fouad K, Schnell L, Bunge MB, et al: Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci 25:1169-1178, 2005
58. Fournier AE, GrandPre T, Strittmatter SM: Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409:341-346, 2001
59. Freund P, Schmidlin E, Wannier T, et al: Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med 12:790-792, 2006
60. Freund P, Wannier T, Schmidlin E, et al: Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J Comp Neurol 502:644-659, 2007
61. Garcia-Alias G, Lin R, Akrimi SF, et al: Therapeutic time window for the application of chondroitinase ABC after spinal cord injury. Exp Neurol 210:331-338, 2007
62. Golden KL, Pearse DD, Blits B, et al: Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol 207:203-217, 2007
63. Grillner S: Locomotion in vertebrates: central mechanisms and reflex interaction. Physiol Rev 55:247-304, 1975
64. Grillner S: Neurobiological bases of rhythmic motor acts in vertebrates. Science 228:143-149, 1985
65. Grillner S: The motor infrastructure: from ion channels to neuronal networks. Nat Rev Neurosci 4:573-586, 2003
66. Hagg T, Oudega M: Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 23:264-280, 2006
67. Hammang JP, Archer DR, Duncan ID: Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment. Exp Neurol 147:84-95, 1997
68. Hannila SS, Filbin MT: The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Exp Neurol 209:321-332, 2008
69. Hata K, Fujitani M, Yasuda Y, et al: RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J Cell Biol 173:47-58, 2006
70. Hayes KC, Potter PJ, Hsieh JT, et al: Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury. Arch Phys Med Rehabil 85:29-34, 2004
71. Herrmann JE, Imura T, Song B, et al: STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28:7231-7234, 2008
72. Hill CE, Beattie MS, Bresnahan JC: Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat. Exp Neurol 171:153-169, 2001
73. Hillard VH, Peng H, Zhang Y, et al: Tempol, a nitroxide antioxidant, improves locomotor and histological outcomes after spinal cord contusion in rats. J Neurotrauma 21:1405-1414, 2004
74. Ho CH, Wuermser LA, Priebe MM, et al: Spinal cord injury medicine. 1. Epidemiology and classification. Arch Phys Med Rehabil 88:S49-S54, 2007
75. Hofstetter CP, Holmstrom NA, Lilja JA, et al: Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 8:346-353, 2005
76. Houle JD, Tom VJ, Mayes D, et al: Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci 26:7405-7415, 2006
77. Ikegami T, Nakamura M, Yamane J, et al: Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growthassociated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci 22:3036-3046, 2005
78. Jenkins R, Tetzlaff W, Hunt SP: Differential expression of immediate early genes in rubrospinal neurons following axotomy in rat. Eur J Neurosci 5:203-209, 1993
79. Kakulas BA: Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 42:549-563, 2004
80. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, et al: Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci 26:3377-3389, 2006
81. Keane RW, Kraydieh S, Lotocki G, et al: Apoptotic and antiapoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 60:422-429, 2001
82. Keirstead HS, Nistor G, Bernal G, et al: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694-4705, 2005
83. Kim BG, Dai HN, Lynskey JV, et al: Degradation of chondroitin sulfate proteoglycans potentiates transplant-mediated axonal remodeling and functional recovery after spinal cord injury in adult rats. J Comp Neurol 497:182-198, 2006
84. Kim GM, Xu J, Xu J, et al: Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J Neurosci 21:6617-6625, 2001
85. Koda M, Okada S, Nakayama T, et al: Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice. Neuroreport 16:1763-1767, 2005
86. Koshizuka S, Okada S, Okawa A, et al: Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol 63:64-72, 2004
87. Kwon BK, Tetzlaff W, Grauer JN, et al: Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4:451-464, 2004
88. Lasiene J, Shupe L, Perlmutter S, et al: No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. J Neurosci 28:3887-3896, 2008
89. Lee YS, Hsiao I, Lin VW: Peripheral nerve grafts and aFGF restore partial hindlimb function in adult paraplegic rats. J Neurotrauma 19:1203-1216, 2002
90. Lehmann M, Fournier A, Selles-Navarro I, et al: Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 19:7537-7547, 1999
91. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622, 1994
92. Liu S, Qu Y, Stewart TJ, et al: Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 97:6126-6131, 2000
93. Llado J, Haenggeli C, Maragakis NJ, et al: Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 27:322-331, 2004
94. Lou J, Lenke LG, Ludwig FJ, et al: Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 36:683-690, 1998
95. Low K, Culbertson M, Bradke F, et al: Netrin-1 is a novel myelinassociated inhibitor to axon growth. J Neurosci 28:1099-1108, 2008
96. Loy DN, Kim JH, Xie M, et al: Diffusion tensor imaging predicts hyperacute spinal cord injury severity. J Neurotrauma 24:979-990, 2007
97. Lu P, Jones LL, Snyder EY, et al: Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181:115-129, 2003
98. Maherali N, Sridharan R, Xie W, et al: Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70, 2007
99. Martin GR: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78:7634-7638, 1981
100. McDonald JW, Becker D, Sadowsky CL, et al: Late recovery following spinal cord injury. Case report and review of the literature. J Neurosurg 97:252-265, 2002
101. McDonald JW, Belegu V: Demyelination and remyelination after spinal cord injury. J Neurotrauma 23:345-359, 2006
102. McDonald JW, Liu XZ, Qu Y, et al: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5:1410-1412, 1999
103. McDonald JW, Sadowsky C: Spinal-cord injury. Lancet 359:417-425, 2002
104. McKeon RJ, Schreiber RC, Rudge JS, et al: Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 11:3398-3411, 1991
105. McKerracher L, David S, Jackson DL, et al: Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13:805-811, 1994
106. McKerracher L, Higuchi H: Targeting Rho to stimulate repair after spinal cord injury. J Neurotrauma 23:309-317, 2006
107. Mi S, Lee X, Shao Z, et al: LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221-228, 2004
108. Monnier PP, Sierra A, Schwab JM, et al: The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci 22:319-330, 2003
109. Moreau-Fauvarque C, Kumanogoh A, Camand E, et al: The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci 23:9229-9239, 2003
110. Morgenstern DA, Asher RA, Fawcett JW: Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res 137:313-332, 2002
111. Mukhopadhyay G, Doherty P, Walsh FS, et al: A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13:757-767, 1994
112. Nagata S, Golstein P: The Fas death factor. Science 267:1449- 1456, 1995
113. Nakagawa M, Koyanagi M, Tanabe K, et al: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106, 2008
114. Nashmi R, Fehlings MG: Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience 104:235-251, 2001
115. Nashmi R, Fehlings MG: Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res Brain Res Rev 38:165-191, 2001
116. Nistor GI, Totoiu MO, Haque N, et al: Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49:385-396, 2005
117. Noble LJ, Wrathall JR: Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res 482:57-66, 1989
118. Norenberg MD, Smith J, Marcillo A: The pathology of human spinal cord injury: defining the problems. J Neurotrauma 21:429-440, 2004
119. Park E, Velumian AA, Fehlings MG: The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754-774, 2004
120. Park IH, Zhao R, West JA, et al: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146, 2008
121. Park JB, Yiu G, Kaneko S, et al: A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 45:345-351, 2005
122. Parr AM, Tator CH, Keating A: Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 40:609-619, 2007
123. Pearse DD, Sanchez AR, Pereira FC, et al: Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia 55:976-1000, 2007
124. Phinney DG, Prockop DJ: Concise review: mesenchymal stem/ multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25:2896- 2902, 2007
125. Pineau I, Lacroix S: Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500:267-285, 2007
126. Pinzon A, Calancie B, Oudega M, et al: Conduction of impulses by axons regenerated in a Schwann cell graft in the transected adult rat thoracic spinal cord. J Neurosci Res 64:533-541, 2001
127. Popovich PG, Wei P, Stokes BT: Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377:443-464, 1997
128. Priebe MM, Chiodo AE, Scelza WM, et al: Spinal cord injury medicine. 6. Economic and societal issues in spinal cord injury. Arch Phys Med Rehabil 88:S84-S88, 2007
129. Quencer RM, Bunge RP: The injured spinal cord: imaging, histopathologic clinical correlates, and basic science approaches to enhancing neural function after spinal cord injury. Spine 21:2064-2066, 1996
130. Radojicic M, Reier PJ, Steward O, et al: Septations in chronic spinal cord injury cavities contain axons. Exp Neurol 196:339- 341, 2005
131. Ragnarsson KT: Functional electrical stimulation after spinal cord injury: current use, therapeutic effects and future directions. Spinal Cord 46:255-274, 2008
132. Raisman G, Li Y: Repair of neural pathways by olfactory ensheathing cells. Nat Rev Neurosci 8:312-319, 2007
133. Ramon-Cueto A, Cordero MI, Santos-Benito FF, et al: Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25:425-435, 2000
134. Ramon-Cueto A, Plant GW, Avila J, et al: Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci 18:3803- 3815, 1998
135. Reubinoff BE, Pera MF, Fong CY, et al: Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399-404, 2000
136. Reynolds BA, Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710, 1992
137. Richardson PM, McGuinness UM, Aguayo AJ: Axons from CNS neurons regenerate into PNS grafts. Nature 284:264- 265, 1980
138. Richter MW, Roskams AJ: Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope? Exp Neurol 209:353-367, 2008
139. Sakamoto A, Ohnishi ST, Ohnishi T, et al: Relationship between free radical production and lipid peroxidation during ischemiareperfusion injury in the rat brain. Brain Res 554:186-192, 1991
140. Schanne FA, Kane AB, Young EE, et al: Calcium dependence of toxic cell death: a final common pathway. Science 206:700-702, 1979
141. Schnell L, Fearn S, Schwab ME, et al: Cytokine-induced acute inflammation in the brain and spinal cord. J Neuropathol Exp Neurol 58:245-254, 1999
142. Schnell L, Schwab ME: Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343:269-272, 1990
143. Schwab ME, Thoenen H: Dissociated neurons regenerate into sciatic but not optic nerve explants in culture irrespective of neurotrophic factors. J Neurosci 5:2415-2423, 1985
144. Scott GS, Cuzzocrea S, Genovese T, et al: Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A 102:3483-3488, 2005
145. Seaberg RM, van der Kooy D: Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci 26:125-131, 2003
146. Sekhon LH, Fehlings MG: Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26:S2- S12, 2001
147. Stoodley MA: Pathophysiology of syringomyelia. J Neurosurg 92:1069-1073, 2000
148. Stys PK, Lipton SA: White matter NMDA receptors: an unexpected new therapeutic target? Trends Pharmacol Sci 28:561-566, 2007
149. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676, 2006
150. Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15-26, 1991
151. Tator CH, Koyanagi I: Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 86:483-492, 1997
152. Temple S, Alvarez-Buylla A: Stem cells in the adult mammalian central nervous system. Curr Opin Neurobiol 9:135-141, 1999
153. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al: Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147, 1998
154. Toma JG, Akhavan M, Fernandes KJ, et al: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778-784, 2001
155. Toma JG, McKenzie IA, Bagli D, et al: Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23:727-737, 2005
156. Totoiu MO, Keirstead HS: Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 486:373- 383, 2005
157. Totoiu MO, Nistor GI, Lane TE, et al: Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol 187:254-265, 2004
158. Vogel G: Cell biology. Ready or not? Human ES cells head toward the clinic. Science 308:1534-1538, 2005
159. Wang KC, Koprivica V, Kim JA, et al: Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417:941-944, 2002
160. Weiss S, Dunne C, Hewson J, et al: Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 16:7599-7609, 1996
161. Westerlund U, Svensson M, Moe MC, et al: Endoscopically harvested stem cells: a putative method in future autotransplantation. Neurosurgery 57:779-784, 2005
162. Wong ST, Henley JR, Kanning KC, et al: A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 5:1302-1308, 2002
163. Wrathall JR, Teng YD, Choiniere D: Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Exp Neurol 137:119-126, 1996
164. Xiong Y, Rabchevsky AG, Hall ED: Role of peroxynitrite in secondary oxidative damage after spinal cord injury. J Neurochem 100:639-649, 2007
165. Xu XM, Guenard V, Kleitman N, et al: Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol 351:145- 160, 1995
166. Yan P, Li Q, Kim GM, et al: Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats. J Neurotrauma 18:563-568, 2001
167. Yick LW, Cheung PT, So KF, et al: Axonal regeneration of Clarke's neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC. Exp Neurol 182:160-168, 2003
168. Yiu G, He Z: Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7:617-627, 2006
169. Yong C, Arnold PM, Zoubine MN, et al: Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J Neurotrauma 15:459-472, 1998
170. Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920, 2007
171. Zhang SC, Ge B, Duncan ID: Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc Natl Acad Sci U S A 96:4089-4094, 1999
172. Guest JD, Hiester ED, Bunge RP: Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol 192:384-393, 2005
173. Tetzlaff W, Kobayashi NR, Giehl KM, et al: Response of rubrospinal and corticospinal neurons to injury and neurotrophins. Prog Brain Res 103:271-286, 1994